An open-label extension study to determine the safety of pirnavanserin in patients with Parkinson's disease and psychosis

被引：0
|
作者：
Mills, R.
Johnson, A.
Bahr, D.
Williams, H.
Revell, S.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
672
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [41] Pimavanserin Safety in Adult and Elderly Patients with Neuropsychiatric Symptoms Related to Neurodegenerative Disease: An Open-Label Extension Study
    Cubala, W.
    Berrio, A.
    Chi-Burris, K.
    Alva, G.
    Chrones, L.
    Pathak, S.
    MOVEMENT DISORDERS, 2024, 39 : S350 - S350
  • [42] Adalimumab in patients with Crohn's disease -: safety and efficacy in an open-label single centre study
    Seiderer, J.
    Brand, S.
    Dambacher, J.
    Pfennig, S.
    Juergens, M.
    Goeke, B.
    Ochsenkuehn, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (07) : 787 - 796
  • [43] LONG-TERM SAFETY AND TOLERABILITY OF PRIDOPIDINE IN PATIENTS WITH HUNTINGTON'S DISEASE (HD): RESULTS OF THE MERMAIHD STUDY OPEN-LABEL EXTENSION
    Squitieri, F.
    Landwehrmeyer, B.
    Reilmann, R.
    Rosser, A.
    Garcia de Yebenes, J.
    Prang, A.
    Ivkovic, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A56 - A57
  • [44] INTERIM LONG-TERM SAFETY/EFFICACY OF RISANKIZUMAB TREATMENT IN CROHN'S DISEASE PATIENTS FROM THE OPEN-LABEL EXTENSION STUDY
    Ferrante, M.
    Panes, J.
    Baert, F.
    Louis, E.
    Kaser, A.
    Gustafson, D.
    Hall, D.
    Boecher, W. O.
    Herichova, I.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G.
    GUT, 2019, 68 : A64 - A64
  • [45] Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open-Label Pilot Study
    Khlebtovsky, Alexander
    Steiner, Israel
    Treves, Therese
    Djaldetti, Ruth
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, : 586 - 590
  • [46] The effect of prucalopride on gastric emptying in Parkinson's disease patients, a pilot randomized, open-label study
    Pinyopornpanish, Kanokwan
    Kijdamrongtham, Phuripong
    Soontornpun, Atiwat
    Teeyasoontranon, Waralee
    Angkurawaranon, Chaisiri
    Thongsawat, Satawat
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 113 - 113
  • [47] Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study (vol 9, 9, 2020)
    Reichmann, Heinz
    Lees, Andrew
    Rocha, Jose-Francisco
    Magalhaes, Diogo
    Soares-da-Silva, Patricio
    TRANSLATIONAL NEURODEGENERATION, 2020, 9 (01)
  • [48] Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: Exploratory Outcomes and Open-Label Extension
    Lizarraga, Karlo J.
    Gnanamanogaran, Bhairavei
    Al-Ozzi, Tameem M.
    Cohn, Melanie
    Tomlinson, George
    Boutet, Alexandre
    Elias, Gavin J. B.
    Germann, Juergen
    Soh, Derrick
    Kalia, Suneil K.
    Hodaie, Mojgan
    Munhoz, Renato P.
    Marras, Connie
    Hutchison, William D.
    Lozano, Andres M.
    Lang, Anthony E.
    Fasano, Alfonso
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (11): : 1421 - 1426
  • [49] Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial
    Pagano, Gennaro
    Monnet, Annabelle
    Reyes, Adriana
    Ribba, Benjamin
    Svoboda, Hanno
    Kustermann, Thomas
    Simuni, Tanya
    Postuma, Ronald B.
    Pavese, Nicola
    Stocchi, Fabrizio
    Brockmann, Kathrin
    Smigorski, Krzysztof
    Gerbaldo, Valentina
    Fontoura, Paulo
    Doody, Rachelle
    Kerchner, Geoffrey A.
    Brundin, Patrik
    Marek, Kenneth
    Bonni, Azad
    Nikolcheva, Tania
    NATURE MEDICINE, 2024, 30 (12) : 3669 - 3675
  • [50] Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
    Gleich, Gerald J.
    Roufosse, Florence
    Chupp, Geoffrey
    Faguer, Stanislas
    Walz, Bastian
    Reiter, Andreas
    Yancey, Steven W.
    Bentley, Jane H.
    Steinfeld, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4431 - +
12345